Net Income (TTM) Chart

View Net Income (TTM) for ONC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 657.23M
March 31, 2026 514.49M
December 31, 2025 287.73M
September 30, 2025 69.60M
June 30, 2025 -176.76M
March 31, 2025 -391.82M
December 31, 2024 -644.24M
September 30, 2024 -860.46M
June 30, 2024 -523.70M
March 31, 2024 -784.43M
December 31, 2023 -881.71M
September 30, 2023 -959.49M
June 30, 2023 -1.732B
March 31, 2023 -1.914B
December 31, 2022 -2.001B
September 30, 2022 -2.147B
June 30, 2022 -2.029B
March 31, 2022 -1.947B
December 31, 2021 -1.444B
September 30, 2021 -1.325B
June 30, 2021 -1.313B
Date Value
March 31, 2021 -1.169B
December 31, 2020 -1.601B
September 30, 2020 -1.516B
June 30, 2020 -1.398B
March 31, 2020 -1.147B
December 31, 2019 -950.58M
September 30, 2019 -829.39M
June 30, 2019 -665.22M
March 31, 2019 -736.99M
December 31, 2018 -674.03M
September 30, 2018 -506.60M
June 30, 2018 -244.83M
March 31, 2018 -147.79M
December 31, 2017 -93.30M
September 30, 2017 -31.62M
June 30, 2017 -184.40M
March 31, 2017 -147.84M
December 31, 2016 -119.22M
September 30, 2016 -108.87M
June 30, 2016 -103.23M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Basilea Pharmaceutica AG 66.07M
Santhera Pharmaceuticals Holding AG -58.05M
AC Immune SA -54.32M
CRISPR Therapeutics AG -451.14M
Idorsia Ltd. -398.11M